In this study, we could show in a well characterized and highly homogeneous population of PCa patients with BCR after RP that PSMA PET/CT findings are robust and reliable and offer an excellent detection rate even in patients with low PSA values < 0.6 ng/ml. This evidence concerns the gene FOLH1 and posterior cortical atrophy.